Sharon Mates

Companies

• Seaport Therapeutics, Inc.Board member Apr 30, 2026 to now¹
• Benitec Biopharma LtdBoard member Nov 7, 2025 to now²
• Intra-Cellular Therapies, Inc.Chief executive officer Sep 9, 2013 to Apr 2, 2025³
• Intra-Cellular Therapies, Inc.Chair Sep 9, 2013 to Apr 2, 2025³
• Intra-Cellular Therapies, Inc.President Sep 9, 2013 to Mar 11, 2024³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ICIntra-Cellular Therapies, Inc.0 shares⁴Apr 2, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 2, 2025Returned to company 190,000 shares at $132.00 of Intra-Cellular Therapies, Inc.⁴
• Apr 2, 2025Returned to company 945,235 shares at $132.00 of Intra-Cellular Therapies, Inc.⁴
• Mar 26, 2025Gift 190,000 shares of Intra-Cellular Therapies, Inc.⁵
• Mar 26, 2025Gift 190,000 shares of Intra-Cellular Therapies, Inc.⁵
• Mar 10, 2025Shares withheld for tax 10,129 shares at $131.24 of Intra-Cellular Therapies, Inc.⁶
• Mar 10, 2025Exercised options 20,566 shares of Intra-Cellular Therapies, Inc.⁶
• Mar 6, 2025Shares withheld for tax 19,848 shares at $131.19 of Intra-Cellular Therapies, Inc.⁶
• Mar 6, 2025Exercised options 40,712 shares of Intra-Cellular Therapies, Inc.⁶
• Mar 1, 2025Shares withheld for tax 16,978 shares at $128.20 of Intra-Cellular Therapies, Inc.⁷
• Mar 1, 2025Exercised options 34,969 shares of Intra-Cellular Therapies, Inc.⁷
• Jan 31, 2025Shares withheld for tax 15,233 shares at $127.00 of Intra-Cellular Therapies, Inc.⁸
• Jan 31, 2025Granted 30,847 shares of Intra-Cellular Therapies, Inc.⁸
• Dec 5, 2024Sold 1,534 shares at $84.69 of Intra-Cellular Therapies, Inc.⁹
• Dec 5, 2024Sold 50,163 shares at $84.06 of Intra-Cellular Therapies, Inc.⁹
• Dec 5, 2024Exercised options 51,697 shares at $12.73 of Intra-Cellular Therapies, Inc.⁹
• Dec 4, 2024Sold 23,333 shares at $86.00 of Intra-Cellular Therapies, Inc.⁹
• Dec 4, 2024Sold 27,667 shares at $85.62 of Intra-Cellular Therapies, Inc.⁹
• Dec 4, 2024Exercised options 51,000 shares at $12.73 of Intra-Cellular Therapies, Inc.⁹
• Aug 30, 2024Sold 6,193 shares at $73.32 of Intra-Cellular Therapies, Inc.¹⁰
• Aug 30, 2024Sold 28,203 shares at $72.73 of Intra-Cellular Therapies, Inc.¹⁰
• Aug 30, 2024Exercised options 34,396 shares at $12.73 of Intra-Cellular Therapies, Inc.¹⁰
• Aug 29, 2024Sold 5,772 shares at $73.25 of Intra-Cellular Therapies, Inc.¹⁰
• Aug 29, 2024Sold 29,832 shares at $72.44 of Intra-Cellular Therapies, Inc.¹⁰
• Aug 29, 2024Exercised options 35,604 shares at $12.73 of Intra-Cellular Therapies, Inc.¹⁰
• Aug 28, 2024Sold 240 shares at $73.70 of Intra-Cellular Therapies, Inc.¹¹